Cross-sectional evaluation of a clinical decision support tool to identify medication-related problems at discharge from the acute care setting

被引:0
|
作者
Dicristina, Savanna [1 ,2 ,3 ,4 ]
Turgeon, Jacques [5 ,6 ]
Michaud, Veronique [5 ,6 ,7 ]
Brunetti, Luigi [1 ,2 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Piscataway, NJ USA
[2] Robert Wood Johnson Barnabas Hlth RWJUH Somerset, Somerville, NJ USA
[3] Tabula Rasa HealthCare, Moorestown, NJ USA
[4] Northeastern Univ, Bouve Coll Hlth Sci, Sch Pharm & Pharmaceut Sci, Boston, MA USA
[5] GalenusRx, Orlando, FL USA
[6] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
[7] CHU Montreal, Ctr Rech, CRCHUM, Montreal, PQ, Canada
关键词
clinical decision support systems; risk score; safety; ADVERSE DRUG-REACTIONS; PHARMACIST; IMPLEMENTATION; PROGRAM; SCORE; RISK;
D O I
10.1002/jac5.1998
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundThere are many reported pharmacist-led transitions of care (TOC) programs to address medication-related problems (MRP) at discharge from the acute care setting. Most have identified time and labor resources as significant limitations. This study aims to assess the effectiveness of a medication risk score (MRS)-driven clinical decision support system (CDSS) in identifying actionable MRPs and improving medication safety in the acute care discharge TOC setting.MethodsA cross-sectional analysis was conducted in a cohort of 481 subjects discharged from the acute care setting. The MRS-CDSS was utilized to identify MRPs and provide recommendations for risk reduction. The distribution of MRPs, recommendations, and their associations with MRS severity were analyzed. Additionally, the potential reduction in MRS per subject and its correlation with MRS severity were examined.ResultsThe median MRS reduction per subject was 2 points, while high/severe-risk patients showed a median potential reduction of 7 points. Among the identified MRPs (n = 691), drug interaction, drug use without indication, and adverse drug reaction accounted for 89.7% of all MRPs. The top three recommendations, discontinue medication, change the time of administration, and start alternative therapy, represented 94.1% of all recommendations. Stratified analysis by MRS category revealed a significant increase in adverse drug reaction MRPs and recommendations to discontinue medications with higher MRS severity. The results were consistent with previous outpatient studies, supporting the MRS-CDSS's ability to enhance medication safety.ConclusionThis study demonstrates that the MRS-CDSS effectively identifies actionable MRPs and has the potential to substantially reduce overall pharmacotherapy regimen risk when applied during acute care discharge TOC. The findings support implementable recommendations directed at patient safety and the allocation of health care resources to high-risk patients for maximum benefit.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
  • [1] EVALUATION OF MEDICATION-RELATED CLINICAL DECISION SUPPORT OVERRIDES IN THE INTENSIVE CARE UNIT
    Wong, Adrian
    Amato, Mary
    Seger, Diane L.
    Beeler, Patrick E.
    Dalleur, Olivia
    Dykes, Patricia
    Eguale, Tewodros
    Fiskio, Julie
    Silvers, Elizabeth R.
    Slight, Sarah P.
    Bates, David W.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S217 - S217
  • [2] Evaluation of medication-related clinical decision support alert overrides in the intensive care unit
    Wong, Adrian
    Amato, Mary G.
    Seger, Diane L.
    Slight, Sarah P.
    Beeler, Patrick E.
    Dykes, Patricia C.
    Fiskio, Julie M.
    Silvers, Elizabeth R.
    Orav, E. John
    Eguale, Tewodros
    Bates, David W.
    JOURNAL OF CRITICAL CARE, 2017, 39 : 156 - 161
  • [3] EVALUATION OF HARM ASSOCIATED WITH OVERRIDDEN MEDICATION-RELATED CLINICAL DECISION SUPPORT
    Wong, Adrian
    Amato, Mary
    Seger, Diane
    Wright, Adam
    Beeler, Patrick
    Slight, Sarah
    Bates, David
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [4] Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit
    Wong, Adrian
    Amato, Mary G.
    Seger, Diane L.
    Rehr, Christine
    Wright, Adam
    Slight, Sarah P.
    Beeler, Patrick E.
    Orav, E. John
    Bates, David W.
    BMJ QUALITY & SAFETY, 2018, 27 (09) : 718 - 724
  • [5] Clinical Decision Support as a Prevention Tool for Medication Errors in the Operating Room: A Retrospective Cross-Sectional Study
    Amici, Lynda D.
    van Pelt, Maria
    Mylott, Laura
    Langlieb, Marin
    Nanji, Karen C.
    ANESTHESIA AND ANALGESIA, 2024, 139 (04): : 832 - 839
  • [6] Development of a Perioperative Medication-Related Clinical Decision Support Tool to Prevent Medication Errors: An Analysis of User Feedback
    Nanji, Karen C.
    Garabedian, Pamela M.
    Shaikh, Sofia D.
    Langlieb, Marin E.
    Boxwala, Aziz
    Gordon, William J.
    Bates, David W.
    APPLIED CLINICAL INFORMATICS, 2021, 12 (05): : 984 - 995
  • [7] Improvement in Pharmacy Student Responses to Medication-Related Problems with and without Clinical Decision Support Alerts
    Stultz, Jeremy S.
    Shelton, Chasity M.
    Kiles, Tyler M.
    Wheeler, James S.
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2023, 87 (05)
  • [8] DEVELOPING PHARMACIE-4-A SIMPLE RISK TOOL TO IDENTIFY PATIENTS AT RISK OF MEDICATION-RELATED PROBLEMS POST-DISCHARGE
    Clifford, Rhonda
    Criddle, Deirdre
    Devine, Benjamin
    Gupta, Shetaal
    Chong, Yee Ling
    Tan, Michelle
    Sanfilippo, Frank
    Etherton-Beer, Christopher
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2018, 14 (08): : E40 - E40
  • [9] The tradeoffs between safety and alert fatigue: Data from a national evaluation of hospital medication-related clinical decision support
    Co, Zoe
    Holmgren, A. Jay
    Classen, David C.
    Newmark, Lisa
    Seger, Diane L.
    Danforth, Melissa
    Bates, David W.
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2020, 27 (08) : 1252 - 1258
  • [10] Developing PHarmacie-4: A simple risk tool to identify patients at risk of medication-related problems post-discharge
    Clifford, R. M.
    Criddle, D.
    Devine, B.
    Sanfillippo, F.
    Etherton-Beer, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (02) : 594 - 594